Trial Update August 21, 2026

Nesiritide-Linked Trial NCT06137742 Marked Completed

On August 21, 2026, the clinical trial registry updated the status of study NCT06137742 to completed. The trial, titled "A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension," is listed as Phase 1/Phase 2. It examined healthy adult participants as well as individuals with pulmonary arterial hypertension. This entry is associated with nesiritide, which carries an unapproved research status. The record indicates the study has reached completion, but no results or outcome data are included in this update. No findings, efficacy claims, or safety conclusions are stated in the available event information. The registry entry provides only the trial title, phase, and current status as of the listed date. Readers should note that a completed status reflects the conclusion of the study's active phase, not a summary of its results. Further details on trial outcomes, if and when posted, would appear separately in the registry record. For additional background on this compound and its general research context, readers can consult the compound overview.

See the full nesiritide overview

Source: https://clinicaltrials.gov/study/NCT06137742